Anastrozole-Induced Dermatitis: Report of a Woman with an Anastrozole-Associated Dermatosis and a Review of Aromatase Inhibitor-Related Cutaneous Adverse Events

Anastrozole is an aromatase inhibitor. Anastrozole competitively inhibits the aromatase enzyme, which synthesizes estrogen. It is used for estrogen receptor-positive breast cancers. A woman with breast cancer and anastrozole-induced dermatitis is described; the cutaneous side effects associated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yoo Jung, Cohen, Philip R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994559/
https://www.ncbi.nlm.nih.gov/pubmed/31965545
http://dx.doi.org/10.1007/s13555-020-00353-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994559/
https://www.ncbi.nlm.nih.gov/pubmed/31965545
http://dx.doi.org/10.1007/s13555-020-00353-3

Ejemplares similares